← Back to articles

SAFE Agreement Mechanics: Why It Is Not Equity Yet

The SAFE vs. Convertible Note Distinction

If convertible notes are debt pretending to be equity, SAFEs are equity arrangements that intentionally aren't equity (yet). Created by Y Combinator in 2013, SAFEs have become the default seed instrument in many markets, especially for smaller rounds or accelerator cohorts. Understanding their mechanics is critical because they sit in a legal gray zone that impacts your cap table in non-obvious ways.

The core distinction: A SAFE is not a debt instrument and is not equity. It's a contractual right to convert to future equity under specific triggering events. This has real implications for how you model your cap table and plan your funding path.

The SAFE Structure: MFN, Discount, and Cap

SAFEs convert to equity under three triggering events: (1) Priced equity round, (2) Acquihire or acquisition, (3) Dissolution. Most SAFEs never trigger the third (unless something goes wrong), so let's focus on the first two.

Priced equity round: When you raise Series A at a specific price, SAFEs convert to the same equity being issued. Using discount and cap mechanics, similar to convertible notes.

Acquihire/acquisition: If you're acquired before a priced round, SAFEs typically convert to common stock or may be purchased out separately depending on terms.

SAFEs include an MFN (Most Favored Nation) clause. If you issue SAFEs to investor A on a 20% discount and later issue SAFEs to investor B on a 25% discount, investor A's SAFE automatically upgrades to 25%. This keeps seed financing aligned without needing to amend every agreement.

Post-Money SAFEs: Cap Table Clarity

Early SAFEs were "pre-money," which created cap table confusion (your founders' ownership was unclear until conversion). Modern SAFEs are post-money, which means the SAFE is calculated as a percentage of the post-money valuation (including the SAFE itself).

Example with post-money SAFE:

You have 5M shares outstanding (founders + options). You raise $500K on a post-money SAFE with a $4M post-money valuation and 20% discount.

The post-money valuation is $4M. Your company has 5M shares + the SAFE holder's future shares = $4M valuation. This means the price per share is $4M / (5M + future shares). Working backward, the SAFE holder's future ownership is $500K / $4M = 12.5% (625K shares if we keep 5M for founders/existing holders).

On your cap table before Series A closes:

• Founders + employees: 5M shares (100%)
• SAFE holder: Not listed as shares, but noted as pending conversion

On your fully diluted cap table:

• Founders + employees: 5M shares (87.5%)
• SAFE holder: 625K shares (12.5%) — as if converted

Why this matters: When you're sizing your option pool, calculating Series A dilution, or assessing investor requirements, you use fully diluted. The SAFE holder's 625K shares count toward your fully diluted capitalization even though they're not technically shares yet.

SAFE Conversion at Priced Round: Discount and Cap

At Series A, SAFEs convert similarly to convertible notes. Your investor invests at a specific post-money valuation. SAFEs convert using the lower of discount valuation or cap valuation.

Example: $500K SAFE, 25% discount, $5M cap. Series A: $10M at $40M post-money.

Discount valuation = $40M × 0.75 = $30M

Cap valuation = $5M

Lower (more favorable to SAFE holder) = $5M

Conversion price per share = $5M / 10M existing shares = $0.50/share (assuming 10M baseline)

SAFE holder receives = $500K / $0.50 = 1M shares

Series A investors paid at a $40M valuation; SAFE holder converted at a $5M valuation. This is the entire value proposition of early SAFEs—you get a discount for taking risk and accepting valuation uncertainty.

Critical: SAFEs Don't Count as Shares on Your Cap Table (Until Conversion)

This is the biggest source of confusion. Many founders treat SAFEs as equity grants that appear on the cap table immediately. They don't. SAFEs are contractual agreements to receive future equity.

Pre-Series A cap table (shares only): SAFEs don't appear.

Fully diluted cap table (all future shares): SAFEs appear as if converted.

When Series A closes, SAFEs trigger conversion and then appear on your cap table as actual shares.

Why this distinction matters: If you raised $500K in SAFEs and you're sizing your option pool, you can't allocate "5% to options" of the common shares and ignore SAFEs. You must account for SAFE dilution in your fully diluted calculation to understand what 5% actually means in terms of share count.

SAFEs Without a Priced Round: A Dangerous Gray Area

What if you raise $2M in SAFEs and never do a Series A? You bootstrap to profitability or get acquired for $20M. What happens to the SAFEs?

Typical SAFE provision: If acquired, SAFEs convert to common stock at a price determined by the SAFE terms (usually discount/cap of the acquisition price). You could have a situation where your SAFE holders own 20% of the acquired company and founders own 80%, despite founders having taken more operational risk.

Dissolution: If the company shuts down, SAFEs typically come after debt but might rank pari passu (equal to) common stock. Read your SAFE terms carefully.

The risk: If you rely entirely on SAFEs and never price a round, you're creating an unliquidated cap table with unclear ownership percentages. Series A investors will require clarity before they invest.

Comparing SAFEs and Convertible Notes on Cap Table

Convertible notes:

• Debt instrument with interest and maturity date
• Create ticking clock (mature in 24-36 months)
• Interest accrues and increases dilution at conversion
• More complex legally and tax-wise

SAFEs:

• Equity agreement, no debt structure
• No maturity date or interest
• No ticking clock (though they still expect conversion at Series A)
• Simpler documentation and tax treatment
• Don't appear on cap table until conversion

For cap table purposes, SAFEs are cleaner. You don't have to track interest accrual or maturity dates. But they create a different problem: opacity. If you have $2M in SAFEs and $1M in common shares, your actual ownership structure is unclear until those SAFEs convert.

Series A Investor Perspective: SAFEs Can Get Expensive

Series A investors increasingly scrutinize SAFE caps. If you raised $500K at a $4M cap in seed and now raising Series A at a $50M post-money valuation, your SAFE holder is getting a 12.5x multiple on their investment (they own the same percentage as if the company was valued at $4M, not $50M).

This is where MFN clauses and clear seed documentation matter. Series A investors will want to see your SAFE agreement, understand the caps and discounts, and validate that your fully diluted cap table is honest.

Building a Fully Diluted Cap Table with SAFEs

Step 1: List all SAFEs with amounts, post-money valuations, discounts, and caps.

Step 2: For each SAFE, calculate fully-diluted ownership assuming the worst-case conversion (most favorable to SAFE holder).

Step 3: Calculate the ownership percentage of all SAFEs combined.

Step 4: Allocate the remaining percentage to founders, employees, and option pool.

Example: You have 4M shares (founders + early employees). You raised $800K on three SAFEs with various caps. Your fully diluted cap table model assumes all three convert simultaneously at Series A (worst-case for founders). They collectively represent 20% of fully diluted. Therefore, total fully diluted = 4M / 0.80 = 5M shares, with SAFE holders entitled to 1M shares (at conversion).

Key Takeaways

• SAFEs are not equity, debt, or shares—they're contractual rights to future equity
• SAFEs don't appear on your cap table as shares until conversion at priced round
• Fully diluted cap table must include SAFEs as if converted (using discount/cap mechanics)
• Post-money SAFEs are clearer than pre-money; modern SAFEs are post-money
• SAFEs convert using same mechanics as convertible notes: lower of discount or cap valuation
• No interest accrual or maturity dates on SAFEs—simpler than convertible notes
• MFN clauses protect early SAFE holders if you raise at better terms later
• Without a priced round, SAFE cap table remains unclear until acquisition or dissolution

Frequently Asked Questions

If I have $1M in SAFEs and don't raise Series A, can I convert them manually?

Not typically. SAFEs are designed to convert at specific triggering events. You could negotiate a conversion with your SAFE holders, but it would require unanimous consent and you'd need to set a conversion price (likely using 409A valuation). Most SAFE agreements don't allow unilateral founder conversion.

Do SAFE holders have board seats or voting rights before conversion?

No, SAFEs are not equity and don't confer board seats or voting rights. SAFE holders are creditors of a sort (contractual rights holders) but not shareholders. This is a key difference from priced equity rounds, where investors might negotiate board seats.

Can I have both convertible notes and SAFEs in the same funding round?

Yes, and it's increasingly common. Early SAFEs, then convertible notes from different investors, then maybe more SAFEs. Each should have aligned terms (discount, cap) to avoid MFN complications. But your cap table will be more complex to model.

What if my SAFE cap is extremely low (e.g., $2M) and my Series A is $100M post-money?

The SAFE holder gets a massive return (they convert at a $2M valuation when the company is worth $100M). Series A investors will see this and may demand cap adjustments or get frustrated. You can't change the SAFE terms unilaterally—you'd need SAFE holder consent. This is why cap negotiation at seed is important; don't agree to overly generous caps unless you expect rapid valuation growth.

Do SAFEs trigger dilution before or after Series A closes?

At the moment Series A closes, SAFEs convert to equity. The conversion is simultaneous with Series A issuance. So your cap table pre-Series A (common shares only) suddenly expands when SAFEs convert. This is reflected immediately in your fully diluted post-Series A cap table.